SOPH Sophia Genetics
- 4.990
- -0.075-1.48%
- 4.990
- 0.0000.00%
Sophia Genetics News
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPHiA...
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bank of Montreal (NYSE:BMO) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter financial results.Bank of Montreal posted quarterly adjusted
Sophia Genetics Rallies Wednesday After Partnering With Microsoft, Nvidia on Whole Genome Analytics Platform
Sophia Genetics (SOPH) was surging Wednesday morning, with shares of the health care technology company recently jumping over 11%, after the company said it was collaborating with Microsoft (MSFT) and
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling more than 300 points on Wednesday.Shares of HEICO Corporation (NYSE:HEI) rose sharply during Wednesday's session following a second-quarter ear
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that it is...
Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI), Biogen (BIIB) and SOPHiA GENETICS (SOPH)
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that...
Klinikum Klagenfurt Am Wörthersee Is Live With SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am...
SOPHiA GENETICS Triumphs With AI-Driven Growth
Earnings Call Summary | Sophia Genetics(SOPH.US) Q1 2024 Earnings Conference
The following is a summary of the SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript:Financial Performance:SOPHiA GENETICS reported Q1 revenue of $15.8 million, a 13% increase from the same qu
RBC Capital Remains a Buy on SOPHiA GENETICS (SOPH)
Sophia Genetics Q1 Loss Narrows, Revenue Up
SOPHiA GENETICS Reaffirms FY24 Revenue $78M-$81M Vs $79.168M Est.
SOPHiA GENETICS Reaffirms FY24 Revenue $78M-$81M Vs $79.168M Est.
Sophia Genetics | 6-K: Report of foreign private issuer (related to financial reporting)
SOPHiA GENETICS Backs 2024 View of Rev $78M-$81M >SOPH
SOPHiA GENETICS Backs 2024 View of Rev $78M-$81M >SOPH
SOPHiA GENETICS Still Sees 2024 Revenue Growth of 25%-30% >SOPH
SOPHiA GENETICS Still Sees 2024 Revenue Growth of 25%-30% >SOPH
Sophia Genetics Q1 2024 GAAP EPS $(0.21) Beats $(0.28) Estimate, Sales $15.779M Miss $16.467M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.28) by 25 percent. This is a 32.26 percent increase over losses of $(0.31)
SOPHiA GENETICS 1Q Loss/Shr 21c >SOPH
SOPHiA GENETICS 1Q Loss/Shr 21c >SOPH
Press Release: SOPHiA GENETICS Reports First Quarter 2024 Results
SOPHiA GENETICS Reports First Quarter 2024 Results Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) --
SOPHiA GENETICS (SOPH) Gets a Buy From RBC Capital
Analysis
Price Target
No Data
